Assessment of Different Threshold Preoperative Glomerular Filtration Rates as Markers of Outcomes in Lung Transplantation  Asishana A. Osho, MPH, Anthony.

Slides:



Advertisements
Similar presentations
The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates  Anthony Castleberry, MD, MMCI, Michael S. Mulvihill,
Advertisements

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Risk Index for Postoperative Acute Kidney Injury After Valvular Surgery Using Cardiopulmonary Bypass  Takashi Yamauchi, MD, PhD, Shigeru Miyagawa, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Lung Transplant Mortality Is Improving in Recipients With a Lung Allocation Score in the Upper Quartile  Todd C. Crawford, MD, Joshua C. Grimm, MD, J.
Rana O. Afifi, MD, Harleen K. Sandhu, MD, MPH, Amy. E
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis  Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
The predictive value of s-cystatin C for mortality after coronary artery bypass surgery  Alain Dardashti, MD, PhD, Shahab Nozohoor, MD, PhD, Lars Algotsson,
Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation  Don Hayes, MD, MS, Stephen Kirkby,
Existing General Population Models Inaccurately Predict Lung Cancer Risk in Patients Referred for Surgical Evaluation  James M. Isbell, MD, MSCI, Stephen.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Heart Transplantation for the Failing Fontan
Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C
B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A
Long-Term Survival After Arterial Versus Atrial Switch in d-Transposition of the Great Arteries  Alexander Kiener, MD, MPH, Michael Kelleman, MSPH, Courtney.
Refinement of survival prediction in patients undergoing lower extremity bypass surgery: Stratification by chronic kidney disease classification  Christopher.
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,
Castigliano M. Bhamidipati, DO, MS, George J
Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma
Less Is More in Post Pediatric Heart Transplant Care
Lucas W. Thornblade, MD, MPH, Michael S
Operative Results and Outcomes in Children With Shone's Anomaly
Loretta Erhunmwunsee, MD, Brian C
The Survival Benefit of Simultaneous Heart-Kidney Transplantation Extends Beyond Dialysis-Dependent Patients  Arman Kilic, MD, Joshua C. Grimm, MD, Glenn.
Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D
Surgery in Adults With Congenital Heart Disease: Risk Factors for Morbidity and Mortality  Brian Kogon, MD, Joanna Grudziak, MA, Anurag Sahu, MD, Maan.
Anthony Lemaire, MD, William R
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Impact of Extracardiac Vascular Disease on Vein Graft Failure and Outcomes After Coronary Artery Bypass Surgery  Ralf E. Harskamp, MD, John H. Alexander,
Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients  Giovanni Filardo, PhD, MPH,
Jeremiah R. Brown, PhD, Richard P. Cochran, MD, Todd A
The Impact of EuroSCORE II Risk Factors on Prediction of Long-Term Mortality  Fabio Barili, MD, PhD, Davide Pacini, MD, Mariangela D’Ovidio, MS, Nicholas.
Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma  Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,
A Comparative Analysis of Bronchial Stricture After Lung Transplantation in Recipients With and Without Early Acute Rejection  Anthony W. Castleberry,
Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis  Shahid I. Sheikh, MD, Don Hayes,
Ross Versus Non-Ross Aortic Valve Replacement in Children: A 22-Year Single Institution Comparison of Outcomes  John W. Brown, MD, Parth M. Patel, BS,
Transcatheter Aortic Valve Replacement Outcomes in Nonagenarians Stratified by Transfemoral and Transapical Approach  Christian McNeely, MD, Alan Zajarias,
Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer  Raymond U.
Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M
Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L
Lung Function and ECMO After Lung Transplantation
The Simplified Acute Physiology Score II as a Predictor of Mortality in Patients Who Underwent Extracorporeal Membrane Oxygenation for Septic Shock  Myung.
Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts?  Malini Daniel, MD, Carol Chen, MD, Jennifer Chung,
Acute Kidney Injury Increases Mortality After Lung Transplantation
Patient Preferences in Treatment Choices for Early-Stage Lung Cancer
Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A
The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients 
Characteristics of Malignant Pleural Mesothelioma in Women
Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices  Shinichi Fukuhara, MD,
Dhaval Chauhan, MD, Alexis K
William M. Whited, MD, Paul Henley, BS, Erin M
Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W
Medication Nonadherence After Lung Transplantation in Adult Recipients
Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C
Specialty Training and Mortality After Esophageal Cancer Resection
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Dana Y. Fuhrman, DO, MS, Lan G
Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation  Joshua C. Grimm, MD, Vicente Valero, MD, Arman.
Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients  Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,
Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D
Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant  Ryan R. Davies, MD, Shylah Haldeman,
Sagar U. Nigwekar, MD, Praveen Kandula, MD, MPH 
Francisco Alcocer, MD, Marjan Mujib, MD, Bruce Lowman, MD, Mark A
Phillip S. Naimo, BS, Matthew S
Risk of Valve-Related Events After Aortic Valve Repair
Presentation transcript:

Assessment of Different Threshold Preoperative Glomerular Filtration Rates as Markers of Outcomes in Lung Transplantation  Asishana A. Osho, MPH, Anthony W. Castleberry, MD, MMCi, Laurie D. Snyder, MD, MHS, Asvin M. Ganapathi, MD, Sameer A. Hirji, BS, Mark Stafford-Smith, MD, Shu S. Lin, MD, PhD, R. Duane Davis, MD, MBA, Matthew G. Hartwig, MD  The Annals of Thoracic Surgery  Volume 98, Issue 1, Pages 283-290 (July 2014) DOI: 10.1016/j.athoracsur.2014.03.010 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier analysis of survival to 2 years, stratified by GFR above or below specified cutoffs. (A) Cutoff, 50.0 mL/min per 1.73 m2 (historical); (B) Cutoff, 48.0 mL/min per 1.73 m2 (recursive); (C) Cutoff, 77.8 mL/min per 1.73 m2 (receiver operating characteristic, ROC). We observed significant differences in mortality on either side of the historic and recursive partitioning cutoffs. The ROC established cutoff did not generate groups with differing mortality. (CI = confidence interval; HR = hazard ratio.) The Annals of Thoracic Surgery 2014 98, 283-290DOI: (10.1016/j.athoracsur.2014.03.010) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Receiver operating characteristics (ROC) curves displaying the sorting efficiency of Chronic Kidney Disease Epidemiology Collaboration glomerular filtration rate (GFR) for predicting post-lung transplant mortality at 1 year. The GFR value that maximizes the sum of sensitivity and specificity (ie, the ideal cutoff GFR values by the receiver operating characteristics method) is reported along with area under the curve (AUC). (CI = confidence interval.) The Annals of Thoracic Surgery 2014 98, 283-290DOI: (10.1016/j.athoracsur.2014.03.010) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions